BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3086372)

  • 1. Production of elastase and other exoproducts by environmental isolates of Pseudomonas aeruginosa.
    Nicas TI; Iglewski BH
    J Clin Microbiol; 1986 May; 23(5):967-9. PubMed ID: 3086372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites.
    Woods DE; Schaffer MS; Rabin HR; Campbell GD; Sokol PA
    J Clin Microbiol; 1986 Aug; 24(2):260-4. PubMed ID: 3018037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa mutants altered in their sensitivity to the effect of iron on toxin A or elastase yields.
    Sokol PA; Cox CD; Iglewski BH
    J Bacteriol; 1982 Aug; 151(2):783-7. PubMed ID: 6807961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Pseudomonas aeruginosa exotoxin A and elastase as virulence factors in acute lung infection.
    Blackwood LL; Stone RM; Iglewski BH; Pennington JE
    Infect Immun; 1983 Jan; 39(1):198-201. PubMed ID: 6401692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of toxin A excretion-deficient mutants of Pseudomonas aeruginosa PAO1.
    Hamood AN; Ohman DE; West SE; Iglewski BH
    Infect Immun; 1992 Feb; 60(2):510-7. PubMed ID: 1730483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic cleavage of exotoxin A from Pseudomonas aeruginosa: formation of an ADP-ribosyltransferase active fragment by the action of Pseudomonas elastase.
    Sanai Y; Morihara K; Tsuzuki H; Homma JY; Kato I
    FEBS Lett; 1980 Oct; 120(1):131-4. PubMed ID: 6254804
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical and genetic studies of iron-regulated (exotoxin A) and phosphate-regulated (hemolysin phospholipase C) virulence factors of Pseudomonas aeruginosa.
    Vasil ML; Berka RM; Gray GL; Pavlovskis OR
    Antibiot Chemother (1971); 1985; 36():23-39. PubMed ID: 2988425
    [No Abstract]   [Full Text] [Related]  

  • 8. Longitudinal studies of virulence factors of Pseudomonas aeruginosa in cystic fibrosis.
    Burke V; Robinson JO; Richardson CJ; Bundell CS
    Pathology; 1991 Apr; 23(2):145-8. PubMed ID: 1745565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of proteases and exotoxin A in the pathogenicity of Pseudomonas aeruginosa infections.
    Wretlind B; Pavlovskis OR
    Scand J Infect Dis Suppl; 1981; 29():13-9. PubMed ID: 6797058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of exoproducts to virulence of Pseudomonas aeruginosa.
    Nicas TI; Iglewski BH
    Can J Microbiol; 1985 Apr; 31(4):387-92. PubMed ID: 2988728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of extracellular virulence factors by Pseudomonas aeruginosa isolates obtained from tracheal, urinary tract, and wound infections.
    Hamood AN; Griswold JA; Duhan CM
    J Surg Res; 1996 Mar; 61(2):425-32. PubMed ID: 8656619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of Pseudomonas aeruginosa virulence factors from clinical and environmental isolates with pathogenicity in the neutropenic mouse.
    Woods DE; Lam JS; Paranchych W; Speert DP; Campbell M; Godfrey AJ
    Can J Microbiol; 1997 Jun; 43(6):541-51. PubMed ID: 9226874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa.
    Mizukane R; Hirakata Y; Kaku M; Ishii Y; Furuya N; Ishida K; Koga H; Kohno S; Yamaguchi K
    Antimicrob Agents Chemother; 1994 Mar; 38(3):528-33. PubMed ID: 8203850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality rates amongst mice with endogenous septicaemia caused by Pseudomonas aeruginosa isolates from various clinical sources.
    Furuya N; Hirakata Y; Tomono K; Matsumoto T; Tateda K; Kaku M; Yamaguchi K
    J Med Microbiol; 1993 Aug; 39(2):141-6. PubMed ID: 8345509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and level of exotoxin A in proteolytic cell-free cultures of clinical isolates of Pseudomonas aeruginosa collected from hospitals in Riyadh, Saudi Arabia.
    al-Ssum RM
    Microbiologica; 1992 Oct; 15(4):355-9. PubMed ID: 1435349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of exotoxin, protease and elastase of Pseudomonas aeruginosa strains isolated from patients' and environmental specimens.
    Sanai Y; Takeshi K; Homma JY; Kamata H
    Jpn J Exp Med; 1978 Dec; 48(6):553-6. PubMed ID: 108441
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations.
    Grimwood K; To M; Rabin HR; Woods DE
    Antimicrob Agents Chemother; 1989 Jan; 33(1):41-7. PubMed ID: 2496657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and characterization of chromosomal insertional mutations of the Pseudomonas aeruginosa exoenzyme S trans-regulatory locus.
    Frank DW; Nair G; Schweizer HP
    Infect Immun; 1994 Feb; 62(2):554-63. PubMed ID: 8300213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme-linked immunosorbent assay for detection of antibodies to Pseudomonas aeruginosa exoproteins.
    Granström M; Wretlind B; Markman B; Pavlovskis OR; Vasil ML
    Eur J Clin Microbiol; 1985 Apr; 4(2):197-200. PubMed ID: 3924608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exotoxin A from various Pseudomonas aeruginosa cultures: in vitro activity measured by enzyme-linked immunosorbent assay (ELISA).
    Ogaard AR; Cryz SJ; Berdal BP
    Acta Pathol Microbiol Immunol Scand B; 1985 Jun; 93(3):217-23. PubMed ID: 3929560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.